Zhejiang Yatai Pharmaceutical Co., Ltd.
SZSE:002370.SZ
4.69 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 405.175 | 420.644 | 373.44 | 315.134 | 514.885 | 709.291 | 1,132.393 | 906.869 | 762.342 | 463.146 | 375.602 | 313.637 | 316.045 | 420.339 | 435.224 | 429.667 | 415.432 | 342.669 | 275.802 |
| Cost of Revenue
| 278.89 | 285.646 | 239.835 | 195.758 | 251.295 | 455.362 | 626.3 | 498.594 | 458.376 | 272.792 | 231.618 | 216.628 | 247.771 | 290.116 | 307.757 | 300.751 | 301.79 | 249.923 | 207.333 |
| Gross Profit
| 126.285 | 134.998 | 133.606 | 119.376 | 263.591 | 253.929 | 506.093 | 408.275 | 303.966 | 190.354 | 143.984 | 97.009 | 68.274 | 130.223 | 127.467 | 128.917 | 113.641 | 92.745 | 68.469 |
| Gross Profit Ratio
| 0.312 | 0.321 | 0.358 | 0.379 | 0.512 | 0.358 | 0.447 | 0.45 | 0.399 | 0.411 | 0.383 | 0.309 | 0.216 | 0.31 | 0.293 | 0.3 | 0.274 | 0.271 | 0.248 |
| Reseach & Development Expenses
| 14.641 | 21.795 | 26.138 | 28.618 | 37.349 | 70.099 | 57.205 | 87.102 | 53.993 | 22.834 | 15.911 | 17.503 | 18.681 | 14.447 | 14.926 | 0 | 8.517 | 3.049 | 2.645 |
| General & Administrative Expenses
| 10.616 | 17.449 | 10.437 | 14.135 | 14.212 | 23.148 | 19.418 | -25.634 | -12.242 | 12.086 | 7.197 | 6.16 | 5.944 | 7.667 | 12.849 | 31.389 | 7.418 | 7.948 | 7.546 |
| Selling & Marketing Expenses
| 37.064 | 58.035 | 72.429 | 140.876 | 205.433 | 197.55 | 156.806 | 128.082 | 66.417 | 58.264 | 45.532 | 44.765 | 51.234 | 45.649 | 30.249 | 30.578 | 27.436 | 20.765 | 17.117 |
| SG&A
| 47.68 | 123.139 | 82.867 | 155.011 | 219.645 | 220.699 | 176.224 | 102.448 | 54.174 | 70.35 | 52.729 | 50.925 | 57.177 | 53.316 | 43.098 | 61.967 | 34.853 | 28.713 | 24.663 |
| Other Expenses
| 35.808 | 51.89 | 33.765 | 58.723 | 65.212 | 83.689 | 0.028 | -0.005 | 8.65 | 3.151 | 2.778 | -0.015 | -2.691 | 5.426 | 0.301 | -0.048 | 2.471 | -0.197 | 0.112 |
| Operating Expenses
| 98.129 | 198.451 | 142.77 | 242.352 | 322.206 | 374.487 | 307.881 | 245.158 | 168.08 | 127.507 | 97.422 | 92.437 | 98.686 | 87.65 | 77.53 | 64.099 | 58.2 | 42.191 | 35.328 |
| Operating Income
| 28.155 | -63.453 | -16.171 | -122.975 | -58.616 | -120.558 | 174.528 | 163.45 | 101.725 | 62.969 | 45.618 | 5.815 | -28.639 | 45.077 | 47.988 | 57.082 | 46.139 | 50.301 | 27.342 |
| Operating Income Ratio
| 0.069 | -0.151 | -0.043 | -0.39 | -0.114 | -0.17 | 0.154 | 0.18 | 0.133 | 0.136 | 0.121 | 0.019 | -0.091 | 0.107 | 0.11 | 0.133 | 0.111 | 0.147 | 0.099 |
| Total Other Income Expenses Net
| 6.33 | 51.89 | -99.324 | -93.037 | -22.691 | -1,801.007 | 0.028 | -0.005 | -50.868 | 3.017 | 0.019 | -0.015 | -2.691 | 5.365 | 0.301 | -6.754 | -6.134 | -0.236 | 0.112 |
| Income Before Tax
| 34.485 | -11.564 | -135.318 | -224.163 | 28.398 | -1,921.565 | 174.556 | 163.445 | 110.375 | 65.986 | 48.388 | 5.799 | -31.331 | 50.442 | 48.288 | 57.034 | 48.61 | 50.065 | 27.454 |
| Income Before Tax Ratio
| 0.085 | -0.027 | -0.362 | -0.711 | 0.055 | -2.709 | 0.154 | 0.18 | 0.145 | 0.142 | 0.129 | 0.018 | -0.099 | 0.12 | 0.111 | 0.133 | 0.117 | 0.146 | 0.1 |
| Income Tax Expense
| 0.246 | 0.313 | -2.597 | 4.118 | 1.123 | -0.312 | 22.023 | 23.054 | 11.594 | 9.497 | 7.82 | 0.319 | -5.613 | 6.647 | 6.242 | 8.882 | 7 | 10.978 | 5.997 |
| Net Income
| 34.24 | -11.877 | -132.72 | -228.28 | 27.275 | -1,921.253 | 150.946 | 139.5 | 96.801 | 55.499 | 40.568 | 5.48 | -25.718 | 43.795 | 42.046 | 48.152 | 41.61 | 39.087 | 21.457 |
| Net Income Ratio
| 0.085 | -0.028 | -0.355 | -0.724 | 0.053 | -2.709 | 0.133 | 0.154 | 0.127 | 0.12 | 0.108 | 0.017 | -0.081 | 0.104 | 0.097 | 0.112 | 0.1 | 0.114 | 0.078 |
| EPS
| 0.056 | -0.02 | -0.25 | -0.43 | 0.051 | -3.58 | 0.28 | 0.26 | 0.22 | 0.14 | 0.1 | 0.015 | -0.065 | 0.11 | 0.11 | 0.16 | 0.14 | 0.13 | 0.071 |
| EPS Diluted
| 0.056 | -0.02 | -0.25 | -0.43 | 0.051 | -3.58 | 0.28 | 0.26 | 0.22 | 0.14 | 0.1 | 0.015 | -0.065 | 0.11 | 0.11 | 0.16 | 0.14 | 0.13 | 0.071 |
| EBITDA
| 102.22 | 76.313 | 25.443 | -121.631 | 147.856 | -1,776.896 | 308.195 | 285.588 | 172.912 | 99.735 | 73.39 | 30.995 | -8.168 | 71.886 | 69.357 | 78.918 | 68.133 | 62.962 | 34.545 |
| EBITDA Ratio
| 0.252 | 0.181 | 0.068 | -0.386 | 0.287 | -2.505 | 0.272 | 0.315 | 0.227 | 0.215 | 0.195 | 0.099 | -0.026 | 0.171 | 0.159 | 0.184 | 0.164 | 0.184 | 0.125 |